Genomic characterization and detection of potential therapeutic targets for peritoneal mesothelioma in current practice

May 2, 2024 | Comments Off on Genomic characterization and detection of potential therapeutic targets for peritoneal mesothelioma in current practice

Clinical and Experimental Medicine 2024 April 20 [Link] Job P van Kooten, Michelle V Dietz, Hendrikus Jan Dubbink, Cornelis Verhoef, Joachim G J V Aerts, Eva V E Madsen, Jan…

Risk factors influencing postoperative pleural empyema in patients with pleural mesothelioma: a retrospective single-centre analysis

May 1, 2024 | Comments Off on Risk factors influencing postoperative pleural empyema in patients with pleural mesothelioma: a retrospective single-centre analysis

European Journal of Cardiothoracic Surgery 2024 March 29 [Link] Peter Henschke, Laura Chiara Guglielmetti, Sven Hillinger, Gian-Marco Monsch, Didier Schneiter, Isabelle Opitz, Olivia Lauk Abstract Objectives: Postoperative empyema is a…

Diffuse pleural mesotheliomas with genomic near-haploidization: a newly recognized subset with distinct clinical, histologic, and molecular features

April 30, 2024 | Comments Off on Diffuse pleural mesotheliomas with genomic near-haploidization: a newly recognized subset with distinct clinical, histologic, and molecular features

Clinical Cancer Research 2024 April 7 [Link] Soo-Ryum Yang, Gowtham Jayakumaran, Jamal Benhamida, Christopher A Febres Aldana, Rachel Fanaroff, Jason Chang, Erika Gedvilaite, Liliana B Villafania, Jennifer L Sauter, Michael…

Circulating SMRP and CA-125 before and after pleurectomy decortication for pleural mesothelioma

April 29, 2024 | Comments Off on Circulating SMRP and CA-125 before and after pleurectomy decortication for pleural mesothelioma

Thoracic Cancer 2024 April 16 [Link] Juuso Paajanen, Ahmed Sadek, William G Richards, Yue Xie, Emanuele Mazzola, Kristina Sidopoulos, John Kuckelman, Ritu R Gill, Raphael Bueno Abstract Background: Tumor recurrence…

Development of Patient and Caregiver Conceptual Models Investigating the Health-Related Quality of Life Impacts of Malignant Pleural Mesothelioma

April 26, 2024 | Comments Off on Development of Patient and Caregiver Conceptual Models Investigating the Health-Related Quality of Life Impacts of Malignant Pleural Mesothelioma

The Patient 2024 April 15 [Link] Adam E J Gibson, Waqas Ahmed, Louise Longworth, Bryan Bennett, Melinda Daumont, Liz Darlison Abstract Background: Malignant pleural mesothelioma (MPM) is a rare and…

Emerging New Targets in Systemic Therapy for Malignant Pleural Mesothelioma

April 25, 2024 | Comments Off on Emerging New Targets in Systemic Therapy for Malignant Pleural Mesothelioma

Cancers 2024 March 22 [Link] Karen M Yun, Lyudmila Bazhenova Abstract Malignant pleural mesothelioma (MPM) is a heterogeneous cancer composed of distinct molecular and pathologic subtypes. Unfortunately, MPM is aggressive,…

High mobility group box 1 mediates inflammatory responses in malignant peritoneal mesothelioma

April 24, 2024 | Comments Off on High mobility group box 1 mediates inflammatory responses in malignant peritoneal mesothelioma

International Immunopharmacology 2024 April 12 [Link] Lianfen Wang, Xuesong Wang, Ningning Sun, Weili Liu Abstract Background: Serum high mobility group box 1 (HMGB1) serves as a diagnostic biomarker for malignant…

YAP/TAZ-TEAD signalling axis: A new therapeutic target in malignant pleural mesothelioma

April 23, 2024 | Comments Off on YAP/TAZ-TEAD signalling axis: A new therapeutic target in malignant pleural mesothelioma

Journal of Cellular and Molecular Medicine 2024 April [Link] Kostas A Papavassiliou, Amalia A Sofianidi, Athanasios G Papavassiliou Abstract The Hippo signalling pathway, a highly conserved signalling cassette, regulates organ…

Diagnostic performance of immunohistochemistry markers for malignant pleural mesothelioma diagnosis and subtypes. A systematic review and meta-analysis

April 22, 2024 | Comments Off on Diagnostic performance of immunohistochemistry markers for malignant pleural mesothelioma diagnosis and subtypes. A systematic review and meta-analysis

Pathology, Research, and Practice 2024 March 30 [Link] Rafael Parra-Medina, Juan Pablo Castañeda-González, Viviana Chaves-Cabezas, Juan Pablo Alzate, Juan José Chaves Abstract Background: Malignant pleural mesothelioma (MPM) poses diagnostic challenges…

Low Exposures to Amphibole or Serpentine Asbestos in Germline Bap1-mutant Mice Induce Mesothelioma Characterized by an Immunosuppressive Tumor Microenvironment

April 19, 2024 | Comments Off on Low Exposures to Amphibole or Serpentine Asbestos in Germline Bap1-mutant Mice Induce Mesothelioma Characterized by an Immunosuppressive Tumor Microenvironment

Cancer Research Communications 2024 April 8 [Link] Yuwaraj Kadariya, Eleonora Sementino, Maggie Ruan, Mitchell Cheung, Parham Hadikhani, Hatice U Osmanbeyoglu, Andres J Klein-Szanto, Kathy Cai, Joseph R Testa Abstract Asbestos…

Categories